Skip to main content
OpenTrials

Clinical trial condition

Urinary Bladder Neoplasms

Explore clinical trials studying Urinary Bladder Neoplasms. Study availability and eligibility vary by location and protocol.

1,200 public trials 264 recruiting studies
Refine in advanced search Browse all conditions

Urinary Bladder Neoplasms trial results

Completed

Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer

NCT00118040

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +12 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • South Orange County Surgical Medical Group Inc Laguna Hills, California, United States
  • University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
  • AccuMed Research Associates Garden City, New York, United States
View Trial Details
Completed

Phase II Evaluating Efficacy of Temsirolimus in 2 Line Therapy for Patients With Advanced Bladder Cancer

NCT01827943

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +9 more
Locations
  • CHU de Bordeaux Bordeaux, France
  • Centre François Baclesse Caen, France
  • Centre Jean Perrin Clermont-Ferrand, France
  • CHU Henri Mondor Créteil, France
View Trial Details
Completed

Adaptive Radiotherapy Using Plan Selection for Bladder Cancer

NCT01762527

Conditions
Adverse Effects for Adaptive RT of Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Department of Oncology, Aarhus University Hospital Aarhus, Denmark
  • Herlev Hospital Herlev, Denmark
  • Odense University Hospital Odense, Denmark
View Trial Details
Completed

Utility of Bladder EpiCheck for Detection of Recurrent Urothelial Carcinoma

NCT02647112

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Tubingen University Medical Center Tübingen, Germany
  • Meir Medical Center Kfar Saba, Israel
  • AMC Medical Center Amsterdam, Netherlands
  • ZGT Medical Center Hengelo, Netherlands
View Trial Details
Completed

The Efficacy of the Bladder EpiCheck for Detection of Recurrent Urothelial Cell Carcinoma

NCT02700464

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • The Urology Center of Colorado Denver, Colorado, United States
  • Chesapeake Urology Research Associates Baltimore, Maryland, United States
  • Michigan Institute of Urology, P.C. Troy, Michigan, United States
  • Metro Urology Woodbury, Minnesota, United States
View Trial Details

Related conditions